Bile acids: The role of peroxisomes

Journal of Lipid Research

Volumn 50, Issue 11, 2009, Pages 2139-2147

  Ferdinandusse, Sacha ^a   Denis, Simone ^a   Faust, Phyllis L ^b   Wanders, Ronald J A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

methylacyl CoA racemase deficiency; D bifunctional protein deficiency; Dihydroxycholestanoic acid; Peroxisome defi ciency disorders; Trihydroxycholestanoic acid

Indexed keywords

BILE ACID BLOOD LEVEL; BILE ACID METABOLISM; BILE ACID SYNTHESIS; BILE ACID SYNTHESIS DISORDER; BILIARY TRACT DISEASE; DISORDERS OF PEROXISOMAL FUNCTIONS; HUMAN; PATHOPHYSIOLOGY; PEROXISOME; PRIORITY JOURNAL; REVIEW;

ANIMALS; BILE ACIDS AND SALTS; BIOSYNTHETIC PATHWAYS; HUMANS; PEROXISOMAL DISORDERS; PEROXISOMES;

EID: 70350417306     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R900009-JLR200     Document Type: Review

References (67)

1. Russell, D. W. 2003. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72: 137-174.
2. Mihalik, S. J., S. J. Steinberg, Z. Pei, J. Park, D. G. Kim, A. K. Heinzer, G. Dacremont, R. J. Wanders, D. A. Cuebas, K. D. Smith, and P. A. Watkins. 2002. Participation of two members of the very long-chain acyl-CoA synthetase family in bile acid synthesis and recycling. J. Biol. Chem. 277: 24771-24779.
3. Steinberg, S. J., S. J. Mihalik, D. G. Kim, D. A. Cuebas, and P. A. Watkins. 2000. The human liver-specifi c homolog of very long-chain acyl-CoA synthetase is cholate:CoA ligase. J. Biol. Chem. 275: 15605- 15608.
4. Steinberg, S. J., S. J. Wang, D. G. Kim, S. J. Mihalik, and P. A. Watkins. 1999. Human very-long-chain acyl-CoA synthetase: cloning, topography, and relevance to branched-chain fatty acid metabolism. Biochem. Biophys. Res. Commun. 257: 615-621.
5. Prydz, K., B. F. Kase, I. Bjorkhem, and J. I. Pedersen. 1988. Subcellular localization of 3 alpha, 7 alpha-dihydroxy- and 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoyl-coenzyme A ligase(s) in rat liver. J. Lipid Res. 29: 997-1004.
6. Schepers, L., M. Casteels, K. Verheyden, G. Parmentier, S. Asselberghs, H. J. Eyssen, and G. P. Mannaerts. 1989. Subcellular distribution and characteristics of trihydroxycoprostanoyl-CoA synthetase in rat liver. Biochem. J. 257: 221-229.
7. Une, M., Y. Iguchi, T. Sakamoto, T. Tomita, Y. Suzuki, M. Morita, and T. Imanaka. 2003. ATP-dependent transport of bile acid intermediates across rat liver peroxisomal membranes. J. Biochem. 134: 225-230.
8. Schmitz, W., C. Albers, R. Fingerhut, and E. Conzelmann. 1995. Purification and characterization of an alpha-methylacyl-CoA racemase from human liver. Eur. J. Biochem. 231: 815-822.
9. Schmitz, W., R. Fingerhut, and E. Conzelmann. 1994. Purification and properties of an alpha-methylacyl-CoA racemase from rat liver. Eur. J. Biochem. 222: 313-323.
10. Pedersen, J. I., T. Veggan, and I. Bjorkhem. 1996. Substrate stereospecificity in oxidation of (25S)-3 alpha, 7 alpha, 12 alphatrihydroxy-5 beta-cholestanoyl-CoA by peroxisomal trihydroxy-5 beta-cholestanoyl-CoA oxidase. Biochem. Biophys. Res. Commun. 224: 37-42.
11. van Veldhoven, P. P., K. Croes, S. Asselberghs, P. Herdewijn, and G. P. Mannaerts. 1996. Peroxisomal beta-oxidation of 2-methylbranched acyl-CoA esters: stereospecific recognition of the 2Smethyl compounds by trihydroxycoprostanoyl-CoA oxidase and pristanoyl-CoA oxidase. FEBS Lett. 388: 80-84.
12. Batta, A. K., G. Salen, S. Shefer, B. Dayal, and G. S. Tint. 1983. Confi guration at C-25 in 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta- cholestan-26-oic acid isolated from human bile. J. Lipid Res. 24: 94-96.
13. Shefer, S., F. W. Cheng, A. K. Batta, B. Dayal, G. S. Tint, G. Salen, and E. H. Mosbach. 1978. Stereospecific side chain hydroxylations in the biosynthesis of chenodeoxycholic acid. J. Biol. Chem. 253: 6386-6392.
14. Vanhove, G. F., P. P. Van Veldhoven, M. Fransen, S. Denis, H. J. Eyssen, R. J. Wanders, and G. P. Mannaerts. 1993. The CoA esters of 2-methyl-branched chain fatty acids and of the bile acid intermediates di- and trihydroxycoprostanic acids are oxidized by one single peroxisomal branched chain acyl-CoA oxidase in human liver and kidney. J. Biol. Chem. 268: 10335-10344.
15. Jiang, L. L., T. Kurosawa, M. Sato, Y. Suzuki, and T. Hashimoto. 1997. Physiological role of D-3-hydroxyacyl-CoA dehydratase/ D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein. J. Biochem. (Tokyo). 121: 506-513.
16. Kurosawa, T., M. Sato, T. Yoshimura, L. L. Jiang, T. Hashimoto, and M. Tohma. 1997. Stereospecifi c formation of (24R,25R)-3 alpha,7 alpha,12 alpha,24-tetrahydroxy-5 beta-cholestan-26-oic acid catalyzed with a peroxisomal bifunctional D-3-hydroxyacyl-CoA dehydratase/ D-3-hydroxyacyl-CoA dehydrogenase. Biol. Pharm. Bull. 20: 295-297.
17. Novikov, D., M. Dieuaide-Noubhani, J. R. Vermeesch, B. Fournier, G. P. Mannaerts, and P. P. Van Veldhoven. 1997. The human peroxisomal multifunctional protein involved in bile acid synthesis: activity measurement, deficiency in Zellweger syndrome and chromosome mapping. Biochim. Biophys. Acta. 1360: 229-240.
18. Qin, Y. M., A. M. Haapalainen, D. Conry, D. A. Cuebas, J. K. Hiltunen, and D. K. Novikov. 1997. Recombinant 2-enoyl-CoA hydratase derived from rat peroxisomal multifunctional enzyme 2: role of the hydratase reaction in bile acid synthesis. Biochem. J. 328: 377-382.
19. Antonenkov, V. D., P. P. Van Veldhoven, E. Waelkens, and G. P. Mannaerts. 1997. Substrate specificities of 3-oxoacyl-CoA thiolase A and sterol carrier protein 2/3-oxoacyl-CoA thiolase purified from normal rat liver peroxisomes. Sterol carrier protein 2/3-oxoacyl-CoA thiolase is involved in the metabolism of 2-methylbranched fatty acids and bile acid intermediates. J. Biol. Chem. 272: 26023-26031.
20. Bun-ya, M., M. Maebuchi, T. Kamiryo, T. Kurosawa, M. Sato, M. Tohma, L. L. Jiang, and T. Hashimoto. 1998. Thiolase involved in bile acid formation. J. Biochem. (Tokyo). 123: 347-352.
21. Wanders, R. J., S. Denis, E. van Berkel, F. Wouters, K. W. Wirtz, and U. Seedorf. 1998. Identification of the newly discovered 58 kDa peroxisomal thiolase SCPx as the main thiolase involved in both pristanic acid and trihydroxycholestanoic acid oxidation: implications for peroxisomal beta-oxidation disorders. J. Inherit. Metab. Dis. 21: 302-305.
22. Ferdinandusse, S., and S. M. Houten. 2006. Peroxisomes and bile acid biosynthesis. Biochim. Biophys. Acta. 1763: 1427-1440.
23. Falany, C. N., H. Fortinberry, E. H. Leiter, and S. Barnes. 1997. Cloning, expression, and chromosomal localization of mouse liver bile acid CoA:amino acid N-acyltransferase. J. Lipid Res. 38: 1139-1148.
24. Falany, C. N., M. R. Johnson, S. Barnes, and R. B. Diasio. 1994. Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase. J. Biol. Chem. 269: 19375-19379.
25. He, D., S. Barnes, and C. N. Falany. 2003. Rat liver bile acid CoA:amino acid N-acyltransferase: expression, characterization, and peroxisomal localization. J. Lipid Res. 44: 2242-2249.
26. Visser, W. F., C. W. van Roermund, L. Ijlst, H. R. Waterham, and R. J. Wanders. 2007. Demonstration of bile acid transport across the mammalian peroxisomal membrane. Biochem. Biophys. Res. Commun. 357: 335-340.
27. Kase, B. F., and I. Bjorkhem. 1989. Peroxisomal bile acid-CoA:amino-acid N-acyltransferase in rat liver. J. Biol. Chem. 264: 9220-9223.
28. Pellicoro, A., F. A. van den Heuvel, M. Geuken, H. Moshage, P. L. Jansen, and K. N. Faber. 2007. Human and rat bile acid-CoA:amino acid N-acyltransferase are liver-specifi c peroxisomal enzymes: implications for intracellular bile salt transport. Hepatology.45: 340-348.
29. O'Byrne, J., M. C. Hunt, D. K. Rai, M. Saeki, and S. E. Alexson. 2003. The human bile acid-CoA:amino acid N-acyltransferase functions in the conjugation of fatty acids to glycine. J. Biol. Chem. 278: 34237-34244.
30. Solaas, K., B. F. Kase, V. Pham, K. Bamberg, M. C. Hunt, and S. E. Alexson. 2004. Differential regulation of cytosolic and peroxisomal bile acid amidation by PPAR alpha activation favors the formation of unconjugated bile acids. J. Lipid Res. 45: 1051-1060.
31. Solaas, K., A. Ulvestad, O. Soreide, and B. F. Kase. 2000. Subcellular organization of bile acid amidation in human liver: a key issue in regulating the biosynthesis of bile salts. J. Lipid Res. 41: 1154-1162.
32. Styles, N. A., J. L. Falany, S. Barnes, and C. N. Falany. 2007. Quantifi cation and regulation of the subcellular distribution of bile acid coenzyme A:amino acid N-acyltransferase activity in rat liver. J. Lipid Res. 48: 1305-1315.
33. Clayton, P. T. 1991. Inborn errors of bile acid metabolism. J. Inherit. Metab. Dis. 14: 478-496.
34. van Eldere, J. R., G. G. Parmentier, H. J. Eyssen, R. J. Wanders, R. B. Schutgens, J. Vamecq, F. Van Hoof, B. T. Poll-The, and J. M. Saudubray. 1987. Bile acids in peroxisomal disorders. Eur. J. Clin. Invest. 17: 386-390.
35. Janssen, G., S. Toppet, and G. Parmentier. 1982. Structure of the side chain of the C29 dicarboxylic bile acid occurring in infants with coprostanic acidemia. J. Lipid Res. 23: 456-465.
36. Parmentier, G. G., G. A. Janssen, E. A. Eggermont, and H. J. Eyssen. 1979. C27 bile acids in infants with coprostanic acidemia and occurrence of a 3 alpha,7 alpha,12 alpha-tridhydroxy-5 beta-C29 dicarboxylic bile acid as a major component in their serum. Eur. J. Biochem. 102: 173-183.
37. Lawson, A. M., M. J. Madigan, D. Shortland, and P. T. Clayton. 1986. Rapid diagnosis of Zellweger syndrome and infantile Refsum's disease by fast atom bombardment-mass spectrometry of urine bile salts. Clin. Chim. Acta. 161: 221-231.
38. Une, M., Y. Tazawa, K. Tada, and T. Hoshita. 1987. Occurrence of both (25R)- and (25S)-3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acids in urine from an infant with Zellweger's syndrome. J. Biochem. (Tokyo). 102: 1525-1530.
39. Yousef, I. M., S. Perwaiz T. Lamireau, and B. Tuchweber. 2003. Urinary bile acid profi le in children with inborn errors of bile acid metabolism and chronic cholestasis; screening technique using electrospray tandem mass-spectrometry (ES/MS/MS). Med. Sci. Monit. 9: MT21-MT31.
40. Ferdinandusse, S., H. Overmars, S. Denis, H. R. Waterham, R. J. A. Wanders, and P. Vreken. 2001. Plasma analysis of di- and trihydroxycholestanoic acid diastereoisomers in peroxisomal alphamethylacyl- CoA racemase deficiency. J. Lipid Res. 42: 137-141.
41. Setchell, K. D., J. E. Heubi, K. E. Bove, N. C. O'Connell, T. Brewsaugh, S. J. Steinberg, A. Moser, and R. H. Squires, Jr. 2003. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology. 124: 217-232.
42. van Veldhoven, P. P., G. Vanhove, S. Assselberghs, H. J. Eyssen, and G. P. Mannaerts. 1992. Substrate specifi cities of rat liver peroxisomal acyl-CoA oxidases: palmitoyl-CoA oxidase (inducible acyl-CoA oxidase), pristanoyl-CoA oxidase (non-inducible acyl-CoA oxidase), and trihydroxycoprostanoyl-CoA oxidase. J. Biol. Chem. 267: 20065-20074.
43. Wanders, R. J., S. W. Denis, and G. Dacremont. 1993. Studies on the substrate specifi city of the inducible and non-inducible acyl-CoA oxidases from rat kidney peroxisomes. J. Biochem. (Tokyo). 113: 577-582.
44. Ferdinandusse, S., S. Denis, E. M. Hogenhout, J. Koster, C. W. van Roermund, L. IJlst, A. B. Moser, R. J. Wanders, and H. R. Waterham. 2007. Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Hum. Mutat. 28: 904-912.
45. Une, M., M. Konishi, Y. Suzuki, S. Akaboshi, M. Yoshii, T. Kuramoto, and K. Fujimura. 1997. Bile acid profiles in a peroxisomal D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein defi ciency. J. Biochem. (Tokyo). 122: 655-658.
46. Vreken, P., A. van Rooij, S. Denis, E. G. van Grunsven, D. A. Cuebas, and R. J. Wanders. 1998. Sensitive analysis of serum 3alpha, 7alpha, 12alpha,24-tetrahydroxy- 5beta-cholestan-26-oic acid diastereomers using gas chromatography-mass spectrometry and its application in peroxisomal D-bifunctional protein deficiency. J. Lipid Res. 39: 2452-2458.
47. Cuebas, D. A., C. Phillips, W. Schmitz, E. Conzelmann, and D. K. Novikov. 2002. The role of alpha-methylacyl-CoA racemase in bile acid synthesis. Biochem. J. 363: 801-807.
48. Ferdinandusse, S., S. Denis, P. A. Mooyer, C. Dekker, M. Duran, R. J. Soorani-Lunsing, E. Boltshauser, A. Macaya, J. Gartner, C. B. Majoie, et al. 2006. Clinical and biochemical spectrum of D-bifunctional protein deficiency. Ann. Neurol. 59: 92-104.
49. Ferdinandusse, S., P. Kostopoulos, S. Denis, H. Rusch, H. Overmars, U. Dillmann, W. Reith, D. Haas, R. J. A. Wanders, M. Duran, et al. 2006. Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy. Am. J. Hum. Genet. 78: 1046-1052.
50. Bootsma, A. H., H. Overmars, A. van Rooij, A. E. van Lint, R. J. Wanders, A. H. van Gennip, and P. Vreken. 1999. Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: application for selective screening of peroxisomal disorders. J. Inherit. Metab. Dis. 22: 307-310.
51. Ferdinandusse, S., S. Denis, H. Overmars, L. Van Eeckhoudt, P. P. Van Veldhoven, M. Duran, R. J. Wanders, and M. Baes. 2005. Developmental changes of bile acid composition and conjugation in L- and D-bifunctional protein single and double knockout mice. J. Biol. Chem. 280: 18658-18666.
52. Czuba, B., and D. A. Vessey. 1982. The effect of bile acid structure on the activity of bile acid-CoA:glycine/taurine-N-acetyltransferase. J. Biol. Chem. 257: 8761-8765.
53. Bove, K. E., C. C. Daugherty, W. Tyson, G. Mierau, J. E. Heubi, W. F. Balistreri, and K. D. Setchell. 2000. Bile acid synthetic defects and liver disease. Pediatr. Dev. Pathol. 3: 1-16.
54. Sundaram, S. S., K. E. Bove, M. A. Lovell, and R. J. Sokol. 2008. Mechanisms of disease: inborn errors of bile acid synthesis. Nat. Clin. Pract. Gastroenterol. Hepatol. 5: 456-468.
55. Faust, P. L., D. Banka, R. Siriratsivawong, V. G. Ng, and T. M. Wikander. 2005. Peroxisome biogenesis disorders: the role of peroxisomes and metabolic dysfunction in developing brain. J. Inherit. Metab. Dis. 28: 369-383.
56. Ferdinandusse, S., S. Denis, G. Dacremont, and R. J. Wanders. 2009. Toxicity of peroxisomal C27-bile acid intermediates. Mol. Genet. Metab. 96: 121-128.
57. Palmeira, C. M., and A. P. Rolo. 2004. Mitochondrially-mediated toxicity of bile acids. Toxicology. 203: 1-15.
58. Goldfischer, S., C. L. Moore, A. B. Johnson, A. J. Spiro, M. P. Valsamis, H. K. Wisniewski, R. H. Ritch, W. T. Norton, I. Rapin, and L. M. Gartner. 1973. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science. 182: 62-64.
59. Dirkx, R., I. Vanhorebeek, K. Martens, A. Schad, M. Grabenbauer, D. Fahimi, P. Declercq, P. P. Van Veldhoven, and M. Baes. 2005. Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities. Hepatology. 41: 868-878.
60. Baumgart, E., I. Vanhorebeek, M. Grabenbauer, M. Borgers, P. E. Declercq, H. D. Fahimi, and M. Baes. 2001. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am. J. Pathol. 159: 1477-1494.
61. Hughes, J. L., A. Poulos, E. Robertson, C. W. Chow, L. J. Sheffield, J. Christodoulou, and R. F. Carter. 1990. Pathology of hepatic peroxisomes and mitochondria in patients with peroxisomal disorders. Virchows Arch. A Pathol. Anat. Histopathol. 416: 255-264.
62. Mathis, R. K., J. B. Watkins, P. Szczepanik-Van Leeuwen, and I. T. Lott. 1980. Liver in the cerebro-hepato-renal syndrome: defective bile acid synthesis and abnormal mitochondria. Gastroenterology. 79: 1311-1317.
63. Maeda, K., A. Kimura, Y. Yamato, H. Nittono, H. Takei, T. Sato, H. Mitsubuchi, T. Murai, and T. Kurosawa. 2002. Oral bile acid treatment in two Japanese patients with Zellweger syndrome. J. Pediatr. Gastroenterol. Nutr. 35: 227-230.
64. Setchell, K. D., P. Bragetti, L. Zimmer-Nechemias, C. Daugherty, M. A. Pelli, R. Vaccaro, G. Gentili, E. Distrutti, G. Dozzini, A. Morelli, et al. 1992. Oral bile acid treatment and the patient with Zellweger syndrome. Hepatology. 15: 198-207.
65. Setchell, K. D., and J. E. Heubi. 2006. Defects in bile acid biosynthesis-diagnosis and treatment. J. Pediatr. Gastroenterol. Nutr. 43 (Suppl 1): S17-S22.
66. Keane, M. H., H. Overmars, T. M. Wikander, S. Ferdinandusse, M. Duran, R. J. Wanders, and P. L. Faust. 2007. Bile acid treatment alters hepatic disease and bile acid transport in peroxisome-deficient PEX2 Zellweger mice. Hepatology. 45: 982-997.
67. Liu, Y., J. Binz, M. J. Numerick, S. Dennis, G. Luo, B. Desai, K. I. MacKenzie, T. A. Mansfi eld, S. A. Kliewer, B. Goodwin, et al. 2003. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J. Clin. Invest. 112: 1678-1687.